|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 01982241.0 (espacenet) (Federated) (European Patent Register), 20010904 | | Patent/reg. no. and date | DK/EP 1315520, 20050504 | | Publication date | 20030604 | | Priority no. and date | DE 10043437, 20000904 | | EP pub. no. and date |
EP 1315520 20030604 | | Effective date | | | Applicant/owner | Trion Pharma GmbH, Franfurter Ring 193a
D-80807 München, DE | | Applicant ref. no. | P15554DKEP | | Inventor | Dr. Horst Lindhofer, Brunhildenstrasse 10
80639 München, DE | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) | | Title | Anvendelse af trifunktionelle bispecifikke og trispecifikke antistoffer til behandling af malign ascitis | | Int. application no. | EP2001010184 | | Int. publication no. | WO2002020039 | | Related patent (certificate) | CA 2009 00037 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
